Published Date: 3-Feb-2021
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Asia Pacific Eye Health Supplements Market, published by KBV research, the Asia Pacific Eye Health Supplements Market would witness market growth of 11.4% CAGR during the forecast period (2020-2026).
The China market dominated the Asia Pacific Alpha-Lipoic Acid Market by Country in 2019, and would continue to be a dominant market till 2026. The Japan market is experiencing a CAGR of 13.8% during (2020 - 2026). Additionally, The India market is anticipated to witness a CAGR of 13.8% during (2020 - 2026).
The Tablets market dominated the South Korea Eye Health Supplements Market by Formulation in 2019, growing at a CAGR of 10 % during the forecast period. The Capsules market is estimated to grow at a CAGR of 11% during (2020 - 2026). Additionally, The Others market is expected to witness highest CAGR of 17.3% during (2020 - 2026).
The Age-related Macular Degeneration (AMD) market dominated the South Korea Eye Health thereby, achieving a market value of $17.7 million by 2026. The Dry Eye Syndrome market is exhibiting a CAGR of 11.1% during (2020 - 2026). Additionally, The Inflammation market would showcase highest CAGR of 12.8% during (2020 - 2026).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.
By Ingredient Type
Unique Offerings from KBV Research